The global nanopore technologies market reached a value of US$ 213.8 Million in 2021. Looking forward, the publisher expects the market to reach US$ 476.6 Million by 2027, exhibiting at a CAGR of 13.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Nanopore technology refers to the next-generation molecule sequencing of single-molecule deoxyribonucleic acid (DNA) without the need for polymerase chain reaction (PCR) amplification and chemical labeling of the sample. It offers a relatively high throughput and low-cost genotyping, high mobility for testing, rapid processing of samples in real-time, and label-free, ultralong reads. It is used as a diagnostic tool to provide a fast analysis, eliminate cumbersome amplification and conversion steps, and detect target molecules at very low concentrations and screen panels of biomarkers or genes. Nowadays, the read quality of nanopore technology has improved significantly on account of the introduction of advanced nanopore proteins and chemistries.
The outbreak of the coronavirus disease (COVID-19), in confluence with the urgent need to develop a potential treatment, represents one of the key factors driving the need for nanopore technologies worldwide. Researchers are extensively relying on these technologies to generate data, ranging from initial characterization of the virus genome to the rapid identification of variants, essential to combating the spread of the pandemic. Apart from this, the increasing prevalence of cancer among a significant part of the population due to the rising number of individuals who smoke, drink, and have obesity and chronic inflammation is contributing to the market growth. Nanopore technologies are used in oncology settings for facilitating cancer diagnosis and treatment through the detection and accurate quantification of microRNA. In addition, leading market players are introducing a new generation of sensing technology that uses nanopores embedded in high-tech electronics to perform precise molecular analyses. This technology is gaining widespread adoption in applied settings, such as clinical diagnostics, epidemiology, food safety, agriculture, and environmental science. Such innovations are projected to influence the market positively.
The publisher provides an analysis of the key trends in each sub-segment of the global nanopore technologies market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cyclomics BV, Electronic Biosciences Inc., Inanobio Inc., Nabsys Inc., Ontera Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Quantapore Inc., Roche Holding AG and Tracxn Technologies Limited.
Nanopore technology refers to the next-generation molecule sequencing of single-molecule deoxyribonucleic acid (DNA) without the need for polymerase chain reaction (PCR) amplification and chemical labeling of the sample. It offers a relatively high throughput and low-cost genotyping, high mobility for testing, rapid processing of samples in real-time, and label-free, ultralong reads. It is used as a diagnostic tool to provide a fast analysis, eliminate cumbersome amplification and conversion steps, and detect target molecules at very low concentrations and screen panels of biomarkers or genes. Nowadays, the read quality of nanopore technology has improved significantly on account of the introduction of advanced nanopore proteins and chemistries.
Nanopore Technologies Market Trends:
The outbreak of the coronavirus disease (COVID-19), in confluence with the urgent need to develop a potential treatment, represents one of the key factors driving the need for nanopore technologies worldwide. Researchers are extensively relying on these technologies to generate data, ranging from initial characterization of the virus genome to the rapid identification of variants, essential to combating the spread of the pandemic. Apart from this, the increasing prevalence of cancer among a significant part of the population due to the rising number of individuals who smoke, drink, and have obesity and chronic inflammation is contributing to the market growth. Nanopore technologies are used in oncology settings for facilitating cancer diagnosis and treatment through the detection and accurate quantification of microRNA. In addition, leading market players are introducing a new generation of sensing technology that uses nanopores embedded in high-tech electronics to perform precise molecular analyses. This technology is gaining widespread adoption in applied settings, such as clinical diagnostics, epidemiology, food safety, agriculture, and environmental science. Such innovations are projected to influence the market positively.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global nanopore technologies market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
- Instruments
- Portable
- Benchtop
- Consumables
Breakup by Application:
- DNA Sequencing
- RNA Sequencing
- Others
Breakup by End User:
- Hospitals and Clinics
- Research Institutes
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cyclomics BV, Electronic Biosciences Inc., Inanobio Inc., Nabsys Inc., Ontera Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Quantapore Inc., Roche Holding AG and Tracxn Technologies Limited.
Key Questions Answered in This Report:
- How has the global nanopore technologies market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global nanopore technologies market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global nanopore technologies market and who are the key players?
- What is the degree of competition in the industry?
Frequently Asked Questions about the Global Nanopore Technologies Market
What is the estimated value of the Global Nanopore Technologies Market?
What is the growth rate of the Global Nanopore Technologies Market?
What is the forecasted size of the Global Nanopore Technologies Market?
Who are the key companies in the Global Nanopore Technologies Market?
Report Attribute | Details |
---|---|
No. of Pages | 143 |
Published | March 2022 |
Forecast Period | 2021 - 2027 |
Estimated Market Value ( USD | $ 213.8 Million |
Forecasted Market Value ( USD | $ 476.6 Million |
Compound Annual Growth Rate | 14.2% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Nanopore Technologies Market
6 Market Breakup by Product
7 Market Breakup by Application
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Agilent Technologies Inc.
- Cyclomics BV
- Electronic Biosciences Inc.
- Inanobio Inc.
- Nabsys Inc.
- Ontera Inc.
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California Inc.
- Quantapore Inc.
- Roche Holding AG
- Tracxn Technologies Limited.
Methodology
LOADING...